Cryogenx
Overview
Cryogenx is a medical technology company focused on developing portable body cooling solutions to combat heatstroke and heat-related illnesses. Founded in 2019 by Matt Anderson, the company is headquartered in London, United Kingdom. Cryogenx's innovative approach targets the urgent global challenge of climate-driven heat stress, with their flagship product, the CGX1, designed to provide rapid, on-demand cooling in various settings. As of 2025, the company has raised approximately $3.23 million through funding rounds.
Recent Developments
- July 2025: Cryogenx secured €1.9 million in a Seed funding round, spearheaded by investors like the UK Innovation Science & Seed Fund. The funding aims to accelerate the development and global deployment of the company's CGX1 device, focusing on dual-use applications in defense and various civilian sectors including industry and emergency services.
- June 2024: The company raised £800,000 to enhance its life-saving cooling technologies targeting heatstroke in military and sports contexts.
- Product Advancements: Cryogenx is developing modular versions of their cooling device for ease of use across different environments and is working towards a subscription-based model to secure sustainable revenue streams.
- Strategic Partnerships and Market Expansion: The firm has been focusing on expanding its reach within the UK Ministry of Defence and the US Department of Defense, addressing persistent heat illness challenges. It also explores opportunities across construction, mining, and healthcare markets to tackle climate adaptation.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2019 |
| Headquarters | London, United Kingdom |
| Founders | Matt Anderson |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | British Design Fund |
| Industry | Medical Equipment Manufacturing |
| Number of Employees | 9 |
Early History
Cryogenx's journey began in 2019 with an innovative vision to tackle heat-related illnesses through mobile cooling technology. Spearheaded by founder Matt Anderson, the concept was born out of the necessity for a practical solution as traditional ice bath treatments were largely unfeasible in emergencies or outdoor scenarios. By 2020, the company's primary offering, the CGX1, had successfully combined on-demand cooling with portability, capturing interest within both the medical and industrial domains.
Company Profile and Achievements
Cryogenx has positioned itself as a pivotal player in the medical equipment manufacturing sector, particularly for their innovative heatstroke management technologies. The company's patented technology—described as an 'ice bath in a backpack'—allows rapid cooling comparable to ice water immersion without extensive resources.
- CGX1 Product Launch: The flagship CGX1 device is a revolutionary advancement enabling immediate heatstroke intervention without the need for traditional cold-chain logistics.
- Funding Milestones: Successful funding rounds since 2024 strengthened its market position, allowing expansions into defense and emergency services.
- Recognition in Medical Technology: By 2025, Cryogenx's strategies for tackling climate change-related health risks have earned attention and partnerships with major defense departments globally.
Current Operations and Market Position
Currently, Cryogenx focuses on the mass production of its devices, aiming to fulfill the increasing demand across defense and emergency sectors by 2030. The company holds a strategic advantage by addressing multiple markets affected by extreme heat, achieving competitive edge with their patented cooling system targeted at essential personnel exposed to high temperatures, like military troops and emergency responders.
Conclusion
Cryogenx represents a pioneering force in the medical technology field, offering critical solutions at a time when global warming exacerbates heat-related health emergencies. Through strategic market expansion and robust funding efforts, the company stands poised to significantly mitigate the global health impacts of rising temperatures. Moving forward, Cryogenx aims to broaden its technological applications, bolster manufacturing capabilities, and ultimately become a leader in portable cooling technologies for varied critical applications.